Tirzepatide on the Fast Track

Eli Lilly expects weight-loss drug approval by end of 2023

Mounjaro, a medication used to treat diabetes, was found to deliver 21% weight loss in SURMOUNT study participants. The study, which was led by Intellihealth co-founder Dr. Louis Aronne, showed weight loss results on par with bariatric surgery.

Read the story at NPR

Related News